The Prescription Drug Pricing Act, penned by Senator Charles Grassley, R-Iowa, and co-sponsored by Senator Ron Wyden, D-Oregon, is in a strange point out of limbo, sitting on the Senate’s legislative calendar for months. But if and when it at any time passes, it could stand to help save billions.
Dependent on estimates from the Congressional Spending plan Business office, the bill could help save a lot more than $ninety four billion more than the future ten many years, due in element to strict price reporting controls on pharmaceutical firms and the continuance of drug producer rebates.
At question is what will eventually occur to the bill. Though it passed via the Senate Finance Committee, no vote has nonetheless been taken, and at this place it is really unclear if and when it will.
What is actually THE Affect
The bill’s principal provision would restrict drug price increases in Medicare